VIRIDIAN THERAPEUTICS INC's ticker is VRDN and the CUSIP is 92790C104. A total of 134 filers reported holding VIRIDIAN THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.93 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,264,378 | -37.7% | 669,125 | -3.4% | 1.45% | -40.3% |
| Q2 2023 | $16,484,686 | -6.5% | 692,925 | 0.0% | 2.43% | -7.6% |
| Q1 2023 | $17,628,012 | -12.9% | 692,925 | 0.0% | 2.63% | -10.7% |
| Q4 2022 | $20,240,339 | +11.8% | 692,925 | -21.5% | 2.94% | +32.4% |
| Q3 2022 | $18,109,000 | +291.3% | 882,925 | +120.7% | 2.22% | +216.4% |
| Q2 2022 | $4,628,000 | – | 400,000 | – | 0.70% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 680,768 | $11,376,000 | 2.18% |
| COMMODORE CAPITAL LP | 185,781 | $3,104,000 | 1.24% |
| Ghost Tree Capital, LLC | 300,000 | $5,013,000 | 1.18% |
| Logos Global Management LP | 550,000 | $9,191,000 | 0.90% |
| Atlas Venture Advisors, Inc. | 209,505 | $3,501,000 | 0.65% |
| BVF INC/IL | 463,504 | $7,745,000 | 0.29% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 27,586 | $461,000 | 0.25% |
| Fairmount Funds Management LLC | 35,092 | $581,000 | 0.24% |
| Soleus Capital Management, L.P. | 67,685 | $1,131,000 | 0.20% |
| Cormorant Asset Management, LP | 459,144 | $7,672,000 | 0.17% |